IBDEI3GW ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,58319,1,4,0)
;;=4^E11.321
;;^UTILITY(U,$J,358.3,58319,2)
;;=^5002634
;;^UTILITY(U,$J,358.3,58320,0)
;;=E11.329^^272^2906^67
;;^UTILITY(U,$J,358.3,58320,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58320,1,3,0)
;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58320,1,4,0)
;;=4^E11.329
;;^UTILITY(U,$J,358.3,58320,2)
;;=^5002635
;;^UTILITY(U,$J,358.3,58321,0)
;;=E11.331^^272^2906^68
;;^UTILITY(U,$J,358.3,58321,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58321,1,3,0)
;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58321,1,4,0)
;;=4^E11.331
;;^UTILITY(U,$J,358.3,58321,2)
;;=^5002636
;;^UTILITY(U,$J,358.3,58322,0)
;;=E11.339^^272^2906^69
;;^UTILITY(U,$J,358.3,58322,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58322,1,3,0)
;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58322,1,4,0)
;;=4^E11.339
;;^UTILITY(U,$J,358.3,58322,2)
;;=^5002637
;;^UTILITY(U,$J,358.3,58323,0)
;;=E11.351^^272^2906^70
;;^UTILITY(U,$J,358.3,58323,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58323,1,3,0)
;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58323,1,4,0)
;;=4^E11.351
;;^UTILITY(U,$J,358.3,58323,2)
;;=^5002640
;;^UTILITY(U,$J,358.3,58324,0)
;;=E11.359^^272^2906^71
;;^UTILITY(U,$J,358.3,58324,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58324,1,3,0)
;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58324,1,4,0)
;;=4^E11.359
;;^UTILITY(U,$J,358.3,58324,2)
;;=^5002641
;;^UTILITY(U,$J,358.3,58325,0)
;;=E11.341^^272^2906^72
;;^UTILITY(U,$J,358.3,58325,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58325,1,3,0)
;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
;;^UTILITY(U,$J,358.3,58325,1,4,0)
;;=4^E11.341
;;^UTILITY(U,$J,358.3,58325,2)
;;=^5002638
;;^UTILITY(U,$J,358.3,58326,0)
;;=E11.349^^272^2906^73
;;^UTILITY(U,$J,358.3,58326,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58326,1,3,0)
;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
;;^UTILITY(U,$J,358.3,58326,1,4,0)
;;=4^E11.349
;;^UTILITY(U,$J,358.3,58326,2)
;;=^5002639
;;^UTILITY(U,$J,358.3,58327,0)
;;=E11.9^^272^2906^74
;;^UTILITY(U,$J,358.3,58327,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58327,1,3,0)
;;=3^Type 2 DM w/o Complications
;;^UTILITY(U,$J,358.3,58327,1,4,0)
;;=4^E11.9
;;^UTILITY(U,$J,358.3,58327,2)
;;=^5002666
;;^UTILITY(U,$J,358.3,58328,0)
;;=H35.363^^272^2906^18
;;^UTILITY(U,$J,358.3,58328,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58328,1,3,0)
;;=3^Drusen of Macular,Bilateral
;;^UTILITY(U,$J,358.3,58328,1,4,0)
;;=4^H35.363
;;^UTILITY(U,$J,358.3,58328,2)
;;=^5005660
;;^UTILITY(U,$J,358.3,58329,0)
;;=H35.362^^272^2906^19
;;^UTILITY(U,$J,358.3,58329,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58329,1,3,0)
;;=3^Drusen of Macular,Left Eye
;;^UTILITY(U,$J,358.3,58329,1,4,0)
;;=4^H35.362
;;^UTILITY(U,$J,358.3,58329,2)
;;=^5005659
;;^UTILITY(U,$J,358.3,58330,0)
;;=H35.361^^272^2906^20
;;^UTILITY(U,$J,358.3,58330,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58330,1,3,0)
;;=3^Drusen of Macular,Right Eye
;;^UTILITY(U,$J,358.3,58330,1,4,0)
;;=4^H35.361
;;^UTILITY(U,$J,358.3,58330,2)
;;=^5005658
;;^UTILITY(U,$J,358.3,58331,0)
;;=H04.123^^272^2906^21
;;^UTILITY(U,$J,358.3,58331,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,58331,1,3,0)
;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
;;^UTILITY(U,$J,358.3,58331,1,4,0)
;;=4^H04.123
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3GW 3939 printed Apr 09, 2024@21:06:20 Page 2
IBDEI3GW ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,58319,1,4,0)
+2 ;;=4^E11.321
+3 ;;^UTILITY(U,$J,358.3,58319,2)
+4 ;;=^5002634
+5 ;;^UTILITY(U,$J,358.3,58320,0)
+6 ;;=E11.329^^272^2906^67
+7 ;;^UTILITY(U,$J,358.3,58320,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,58320,1,3,0)
+10 ;;=3^Type 2 DM w/ Mild Nonprolif DM Retinopathy w/o Macular Edema
+11 ;;^UTILITY(U,$J,358.3,58320,1,4,0)
+12 ;;=4^E11.329
+13 ;;^UTILITY(U,$J,358.3,58320,2)
+14 ;;=^5002635
+15 ;;^UTILITY(U,$J,358.3,58321,0)
+16 ;;=E11.331^^272^2906^68
+17 ;;^UTILITY(U,$J,358.3,58321,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,58321,1,3,0)
+20 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/ Macular Edema
+21 ;;^UTILITY(U,$J,358.3,58321,1,4,0)
+22 ;;=4^E11.331
+23 ;;^UTILITY(U,$J,358.3,58321,2)
+24 ;;=^5002636
+25 ;;^UTILITY(U,$J,358.3,58322,0)
+26 ;;=E11.339^^272^2906^69
+27 ;;^UTILITY(U,$J,358.3,58322,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,58322,1,3,0)
+30 ;;=3^Type 2 DM w/ Mod Nonprolif DM Retinopathy w/o Macular Edema
+31 ;;^UTILITY(U,$J,358.3,58322,1,4,0)
+32 ;;=4^E11.339
+33 ;;^UTILITY(U,$J,358.3,58322,2)
+34 ;;=^5002637
+35 ;;^UTILITY(U,$J,358.3,58323,0)
+36 ;;=E11.351^^272^2906^70
+37 ;;^UTILITY(U,$J,358.3,58323,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,58323,1,3,0)
+40 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/ Macular Edema
+41 ;;^UTILITY(U,$J,358.3,58323,1,4,0)
+42 ;;=4^E11.351
+43 ;;^UTILITY(U,$J,358.3,58323,2)
+44 ;;=^5002640
+45 ;;^UTILITY(U,$J,358.3,58324,0)
+46 ;;=E11.359^^272^2906^71
+47 ;;^UTILITY(U,$J,358.3,58324,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,58324,1,3,0)
+50 ;;=3^Type 2 DM w/ Prolif DM Retinopathy w/o Macular Edema
+51 ;;^UTILITY(U,$J,358.3,58324,1,4,0)
+52 ;;=4^E11.359
+53 ;;^UTILITY(U,$J,358.3,58324,2)
+54 ;;=^5002641
+55 ;;^UTILITY(U,$J,358.3,58325,0)
+56 ;;=E11.341^^272^2906^72
+57 ;;^UTILITY(U,$J,358.3,58325,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,58325,1,3,0)
+60 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/ Macular Edema
+61 ;;^UTILITY(U,$J,358.3,58325,1,4,0)
+62 ;;=4^E11.341
+63 ;;^UTILITY(U,$J,358.3,58325,2)
+64 ;;=^5002638
+65 ;;^UTILITY(U,$J,358.3,58326,0)
+66 ;;=E11.349^^272^2906^73
+67 ;;^UTILITY(U,$J,358.3,58326,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,58326,1,3,0)
+70 ;;=3^Type 2 DM w/ Severe Nonprolif DM Retinopathy w/o Macular Edema
+71 ;;^UTILITY(U,$J,358.3,58326,1,4,0)
+72 ;;=4^E11.349
+73 ;;^UTILITY(U,$J,358.3,58326,2)
+74 ;;=^5002639
+75 ;;^UTILITY(U,$J,358.3,58327,0)
+76 ;;=E11.9^^272^2906^74
+77 ;;^UTILITY(U,$J,358.3,58327,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,58327,1,3,0)
+80 ;;=3^Type 2 DM w/o Complications
+81 ;;^UTILITY(U,$J,358.3,58327,1,4,0)
+82 ;;=4^E11.9
+83 ;;^UTILITY(U,$J,358.3,58327,2)
+84 ;;=^5002666
+85 ;;^UTILITY(U,$J,358.3,58328,0)
+86 ;;=H35.363^^272^2906^18
+87 ;;^UTILITY(U,$J,358.3,58328,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,58328,1,3,0)
+90 ;;=3^Drusen of Macular,Bilateral
+91 ;;^UTILITY(U,$J,358.3,58328,1,4,0)
+92 ;;=4^H35.363
+93 ;;^UTILITY(U,$J,358.3,58328,2)
+94 ;;=^5005660
+95 ;;^UTILITY(U,$J,358.3,58329,0)
+96 ;;=H35.362^^272^2906^19
+97 ;;^UTILITY(U,$J,358.3,58329,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,58329,1,3,0)
+100 ;;=3^Drusen of Macular,Left Eye
+101 ;;^UTILITY(U,$J,358.3,58329,1,4,0)
+102 ;;=4^H35.362
+103 ;;^UTILITY(U,$J,358.3,58329,2)
+104 ;;=^5005659
+105 ;;^UTILITY(U,$J,358.3,58330,0)
+106 ;;=H35.361^^272^2906^20
+107 ;;^UTILITY(U,$J,358.3,58330,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,58330,1,3,0)
+110 ;;=3^Drusen of Macular,Right Eye
+111 ;;^UTILITY(U,$J,358.3,58330,1,4,0)
+112 ;;=4^H35.361
+113 ;;^UTILITY(U,$J,358.3,58330,2)
+114 ;;=^5005658
+115 ;;^UTILITY(U,$J,358.3,58331,0)
+116 ;;=H04.123^^272^2906^21
+117 ;;^UTILITY(U,$J,358.3,58331,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,58331,1,3,0)
+120 ;;=3^Dry Eye Syndrome,Bilateral Lacrimal Glands
+121 ;;^UTILITY(U,$J,358.3,58331,1,4,0)
+122 ;;=4^H04.123
